Akèy › Maladi Alzheimer › Colorado
Etid klinik pou Maladi Alzheimer nan Colorado
13 etid pou Maladi Alzheimer ap chèche patisipan nan sit nan Colorado.
Vil nan Colorado
Tèks ofisyèl etid la (Anglè)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Denver
Ap rekriteFaz 2
Laj 55 a 90 · Tout sèks · Mizajou Sep 30, 2026 · NCT06887192A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- CenExel Rocky Mountain Clinical Research, Englewood
Ap rekriteFaz 2
Laj 55 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT07589595Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- CenExel Denver, CO, Englewood
Ap rekriteFaz 2
Laj 55 a 80 · Tout sèks · Mizajou Sep 21, 2026 · NCT06847321A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
- Alpine Clinical Research Center - Boulder - 47th Street /ID# 277856, Boulder
Ap rekriteFaz 1/2
Laj 50 a 90 · Tout sèks · Mizajou Sep 18, 2026 · NCT07599670A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- Research of the Rockies, Colorado Springs
Ap rekriteFaz 3
Laj 60 a 85 · Tout sèks · Mizajou Sep 17, 2026 · NCT06976203Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- University of Colorado Anschutz Medical Campus, Aurora
Ap rekriteFaz 2
Laj 55 a 90 · Tout sèks · Mizajou Sep 1, 2026 · NCT06808984A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Mountain Neurological Research Center, Basalt
Ap rekriteFaz 3
Laj 60 a 85 · Tout sèks · Mizajou Aug 20, 2026 · NCT06976216Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- University of Colorado Anschutz, Aurora
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 4, 2026 · NCT06563895CBD for Individuals at Risk for Alzheimer's Disease
- University of Colorado - Anschutz Medical Campus, Aurora
Ap rekriteFaz 2
Laj 55 a 85 · Tout sèks · Mizajou Jun 15, 2026 · NCT05822362Trial-Ready Cohort-Down Syndrome (TRC-DS)
- Linda Crnic Institute for Down Syndrome, University of Colorado, Aurora
Ap rekriteEtid obsèvasyon
Laj 25 a 55 · Tout sèks · Mizajou May 18, 2026 · NCT04165109Phase II Trial to Evaluate Safety and Efficacy of GM-CSF/Sargramostim in Alzheimer's Disease
- University of Colorado Anschutz Medical Campus, Aurora
Ap rekriteFaz 2
Laj 60 a 85 · Tout sèks · Mizajou Apr 30, 2026 · NCT04902703Intervention to Collect and Utilize Sexual Orientation and Gender Identity (SOGI) Information in Hospice
- University of Colorado, Aurora
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jun 24, 2024 · NCT05877391Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
- Vivage/Beecan Corporation, Lakewood
Ap rekrite
Laj 50 ak plis · Tout sèks · Mizajou Mar 12, 2024 · NCT05820919Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.